Abbott Next Generation Drug Eluting Stent 48mm Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 107 participants.
Also called NCT04282148
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 107 participants
- Sponsor
- Registry
-
NCT04282148
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT04282148. Allocation not applicable; no masking; primary purpose treatment. Start 2020-06-17 (actual); primary completion 2022-10-05 (actual). Results posted on 2024-02-12.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Abbott Next Generation Drug Eluting Stent 48mm Study
- Acronym
- SPIRIT 48
- Condition
- Coronary Artery Disease
- Intervention (Device)
- ABT NG DES 48 EECSS
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct04282148- Content hash
18e992a2c728ea6869b73d47ef995c53f506516ef0cecb33e747eb0872709dfa